GATA3 as an immunomodulator in obesity-related metabolic dysfunction associated with fatty liver disease, insulin resistance, and type 2 diabetes
Amr Ahmed El‐Arabey, Mohnad Abdalla
Topics & Concepts
Insulin resistanceType 2 diabetesEndocrinologyFatty liverAdipose tissueInternal medicineMedicineAdipogenesisObesityInflammationDiabetes mellitusBiologyDiseaseAdipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismCardiovascular Disease and Adiposity